You are here

Bosutinib In Subjects With Renal Impairment

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
DeLand, Florida, 32720 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
End-Stage Renal Disease, Chronic Renal Insufficiency, Acute Renal Insufficiency
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Males and females, aged 18 to 65.

- Adequate hepatic function.

- Documented creatinine clearance by Cockroft-Gault formula indicative of the respective
level of renal impairment: Severe renal impairment (CrCl renal impairment (30 ≤ CrCl ≤50 mL/min/1.73m2), mild renal impairment (50 mL/min/1.73m2) and normal renal function (CrCl >80 mL/min/1.73m2).

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Use of any investigational drug or biologic within 4 weeks prior to the screening
visit of during the screening period.

- Ongoing treatment with Digoxin or strong CYP3A4 inhibitors or inducers.

- Uncontrolled hypertension (for renally impaired subjects only).

NCT01233882
Pfizer
Completed
Bosutinib In Subjects With Renal Impairment

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now